CME Group (CME) reported $1.74 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 13%. EPS of $3.02 for the same period compares to $2.68 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.71 billion, representing a surprise of +1.43%. The company delivered an EPS surprise of +1.34%, with the consensus EPS estimate being $2.98.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how CME performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Average daily volume: 29.45 million versus the four-analyst average estimate of 29.12 million. Average rate per contract- Interest rates: $0.49 versus the four-analyst average estimate of $0.48. Average rate per contract- Equity indexes: $0.61 versus $0.61 estimated by four analysts on average. Average rate per contract- Foreign exchange: $0.85 compared to the $0.82 average estimate based on four analysts. Average rate per contract- Energy: $1.15 versus $1.14 estimated by four analysts on average. Average rate per contract- Agricultural commodities: $1.38 versus $1.43 estimated by four analysts on average. Average daily volume- Metals: 935 thousand versus 948.26 thousand estimated by four analysts on average. Average rate per contract: $0.68 compared to the $0.68 average estimate based on four analysts. Average daily volume- Interest rates: 15.12 million compared to the 14.83 million average estimate based on four analysts. Revenues- Other: $116.1 million compared to the $116.04 million average estimate based on four analysts. The reported number represents a change of +8.3% year over year. Revenues- Market data and information services: $243.1 million compared to the $236.2 million average estimate based on four analysts. The reported number represents a change of +20.1% year over year. Revenues- Clearing and transaction fees: $1.38 billion versus the four-analyst average estimate of $1.36 billion. The reported number represents a year-over-year change of +12.2%.View all Key Company Metrics for CME here>>>
Shares of CME have returned +10.5% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CME Group Inc. (CME): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).